Yüklüyor......
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
OBJECTIVE: To assess the value of blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage and its utility to monitor treatment response in relapsing-remitting multiple sclerosis. METHODS: We measured NfL in blood samples from 589 patient...
Kaydedildi:
| Yayımlandı: | Neurology |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Lippincott Williams & Wilkins
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442011/ https://ncbi.nlm.nih.gov/pubmed/30737333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007032 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|